Does EZETIMIBE Cause Therapeutic product effect incomplete? 147 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 147 reports of Therapeutic product effect incomplete have been filed in association with EZETIMIBE (Ezetimibe). This represents 1.1% of all adverse event reports for EZETIMIBE.
147
Reports of Therapeutic product effect incomplete with EZETIMIBE
1.1%
of all EZETIMIBE reports
0
Deaths
46
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From EZETIMIBE?
Of the 147 reports, 46 (31.3%) required hospitalization, and 9 (6.1%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EZETIMIBE. However, 147 reports have been filed with the FAERS database.
What Other Side Effects Does EZETIMIBE Cause?
Myalgia (2,066)
Fatigue (876)
Drug ineffective (812)
Arthralgia (766)
Dyspnoea (766)
Nausea (742)
Dizziness (717)
Diarrhoea (688)
Headache (626)
Malaise (591)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which EZETIMIBE Alternatives Have Lower Therapeutic product effect incomplete Risk?
EZETIMIBE vs EZETIMIBE\ROSUVASTATIN
EZETIMIBE vs EZETIMIBE\SIMVASTATIN
EZETIMIBE vs EZOGABINE
EZETIMIBE vs FACTOR XIII CONCENTRATE
EZETIMIBE vs FAM-TRASTUZUMAB DERUXTECAN-NXKI